News

COVID-19 vigilance urged ahead of hay fever season

2 October 2020

With COVID-19 still transmitting within community, Alfred Health allergy experts are urging hay fever sufferers not to ignore their symptoms as spring approaches.

covid-19

hay fever

patients

First-in-world cancer trials at The Alfred

25 September 2020

Alfred Cancer Trials (ACT) has begun testing two new Phase 1 cancer drugs, treating the first patients in the world on these trials.

cancer

cancer research

patients

research & innovation

Visitor restrictions at Alfred Health

18 September 2020

A statement from Professor Andrew Way, Chief Executive of Alfred Health, regarding visitor restrictions.

patients

Asthma patients urged to review medication

18 September 2020

Respiratory specialists at The Alfred are urging people with asthma to review their medication after new research found one quarter of people who use inhaler controllers receive potentially toxic cumulative doses of oral corticosteroid.

asthma

patients

research & innovation

Testing AI for skin cancer

16 September 2020

Artificial intelligence (AI) could soon become a powerful tool in skin cancer assessment. The Victorian Melanoma Service is currently conducting a trial into the effectiveness of the technology. 

melanoma

patients

research & innovation

Breathless? Clinic to measure heart health after COVID

4 September 2020

The first specialist clinic in Australia to study the impact of COVID-19 on the heart is opening at The Alfred.

heart

patients

Lockdown leads to fewer people seeking medical care

28 August 2020

Victoria’s State of Emergency (SOE) measures resulted in almost 40 per cent less people presenting to Alfred Health’s emergency departments earlier this year, prompting doctors to issue an urgent call for people to continue seeking medical care if they need it.

emergency & trauma

patients

New hope for brain cancer treatment

28 August 2020

Making up 80 per-cent of all brain tumours in adults, gliomas such as glioblastoma (GBM) are the most common and aggressive form of brain cancer. Killing more people under forty than any other cancer, a quarter of a million people die every year from these tumours – despite current treatment options the average survival for a GBM is only 14-15 months after diagnosis

neurosurgery

research & innovation

staff

Communicating in a mask

12 August 2020

For many of us, wearing a mask is a necessary inconvenience. But for the one in six people in our community who are deaf or hearing impaired, wearing masks can be incredibly isolating. Anthony Cignarella is a nurse educator in our heart and lung team – he’s also hearing impaired. He’s put together some tips on communicating while wearing a mask.

patients

Craig’s second lease on life

31 July 2020

For the first time in fifteen years Craig is able to feel his toes again. Craig received a life changing heart transplant just over two months ago and has never felt more alive.

heart

patients

transplant